跳至主要内容
临床试验/NCT03209076
NCT03209076Unknown不适用

Robotic Versus Laparoscopic Low Anterior Resection for Rectal Cancer: A Randomized Study

Instituto Nacional de Cancer, Brazil2 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2018年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
120
试验地点
2
主要终点
Urinary dysfunction

研究概览

简要总结

Prospective randomized trial comparing robotic versus laparoscopic Low anterior resection for rectal cancer.

Primary endpoint: Compare urinary dysfunction between robotic and laparoscopic approach.

详细描述

Prospective randomized trial comparing robotic versus laparoscopic Low anterior resection for rectal cancer.

The Aim of the study is to compare two surgical approaches (robotic versus laparoscopic) for rectal cancer treatment regarding functional outcomes (sexual and urinary dysfunctions), quality of life, post operative outcomes and oncologic outcomes.

Patients with the diagnosis of T3 mid and low rectal cancer will be randomized to robotic or laparoscopic procedure after neoadjuvant chemoradiation. Quality of life questionnaires and Urodynamic test will be applied before and after the surgical procedures.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Mid or low Rectal Adenocarcinoma
  • Performance Status (ECOG) 0 - 2

排除标准

  • Metastatic disease
  • Congestive heart failure
  • Renal failure
  • Pregnancy
  • Neurologic disorders
  • Alfa blockers user
  • Patients who are candidates to APR ( Abdomino-perineal resection)

研究组 & 干预措施

Robotic

Experimental

Robotic low anterior resection

干预措施: Robotic (Procedure)

Laparoscopic

Active Comparator

Laparoscopic low anterior resection

干预措施: Laparoscopic (Procedure)

结局指标

主要结局

Urinary dysfunction

时间窗: Change from Before surgery to 3 months after surgery

Urodynamic test

次要结局

  • Sexual dysfunction(Change from Before surgery to 3 months after surgery)
  • Post operative outcomes(Within the first 30 days after the surgical procedure)
  • Costs(From the surgical procedure until the last follow up, which will be 24 months or the day of death.)

研究者

发起方
Instituto Nacional de Cancer, Brazil
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Marcus Valadão

Principal Investigator

Instituto Nacional de Cancer, Brazil

研究点 (2)

Loading locations...

相似试验